BIOMAT Database Logo BIOMAT Database Logo

Prevention of chemotherapeutic effects of 4-amino-N10-methyl-pteroylglutamic acid on mouse leukemia by citrovorum factor. 1950

J H BURCHENAL, and G M BABCOCK, and H P BROQUIST, and T H JUKES

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D005493 Folic Acid Antagonists Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) Antifolate,Antifolates,Dihydrofolate Reductase Inhibitor,Folic Acid Antagonist,Dihydrofolate Reductase Inhibitors,Folic Acid Metabolism Inhibitors,Acid Antagonist, Folic,Acid Antagonists, Folic,Antagonist, Folic Acid,Antagonists, Folic Acid,Inhibitor, Dihydrofolate Reductase,Inhibitors, Dihydrofolate Reductase,Reductase Inhibitor, Dihydrofolate,Reductase Inhibitors, Dihydrofolate
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D035843 Biomedical Research Research that involves the application of the natural sciences, especially biology and physiology, to medicine. Medical Research,Experimental Medicine,Investigational Medicine,Investigative Medicine,Research, Biomedical,Research, Medical,Medicine, Experimental,Medicine, Investigational,Medicine, Investigative

Related Publications

J H BURCHENAL, and G M BABCOCK, and H P BROQUIST, and T H JUKES
Prevention of chemotherapeutic effects of 4-amino-N10-methyl-pteroylglutamic acid on mouse leukemia by pteroylglutamic acid.
August 1949, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J H BURCHENAL, and G M BABCOCK, and H P BROQUIST, and T H JUKES
Development of resistance to 4-amino n10-methyl pteroylglutamic acid (Amethopterin) by Leuconostoc citrovorum.
July 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J H BURCHENAL, and G M BABCOCK, and H P BROQUIST, and T H JUKES
Studies on the chemotherapy of leukemia; the effect of 4-amino-pteroylglutamic acid and 4-amino-N10-methyl-pteroylglutamic acid on transplanted mouse leukemia.
January 1949, Cancer,
J H BURCHENAL, and G M BABCOCK, and H P BROQUIST, and T H JUKES
Effects of 4-amino-N10-methyl-pteroylglutamic acid on the extracellular fluids of rats.
June 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J H BURCHENAL, and G M BABCOCK, and H P BROQUIST, and T H JUKES
The effects of 4-amino-N10 methyl-pteroylglutamic acid on the leukocytes of the normal and leukemic mouse.
February 1950, Blood,
J H BURCHENAL, and G M BABCOCK, and H P BROQUIST, and T H JUKES
Inhibition of development of sarcoma 180 by 4-amino-N10-methyl pteroylglutamic acid.
March 1949, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J H BURCHENAL, and G M BABCOCK, and H P BROQUIST, and T H JUKES
Development of resistance to 4-amino-N10-methyl pteroylglutamic acid (Amethopterin) by Streptococcus faecalis.
October 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J H BURCHENAL, and G M BABCOCK, and H P BROQUIST, and T H JUKES
The effect of 4-amino-N10-methyl-pteroylglutamic acid on oral mucosa of experimental animals.
May 1968, Journal of oral therapeutics and pharmacology,
J H BURCHENAL, and G M BABCOCK, and H P BROQUIST, and T H JUKES
The action of 4-amino-N10-methyl-pteroylglutamic acid in mice, rats, and dogs.
March 1950, The Journal of pharmacology and experimental therapeutics,
J H BURCHENAL, and G M BABCOCK, and H P BROQUIST, and T H JUKES
A comparison of the effects of 4-amino-N10-methyl-pteroylglutamic acid and 2,6-diaminopurine upon sensitive and resistant sublines of a strain of mouse leukemia.
April 1951, Blood,
Copied contents to your clipboard!